HOME >> MEDICINE >> NEWS
CIHR-funded research: Antidepressants help men decrease alcohol consumption, but not women

OTTAWA (February 27, 2007) CIHR-funded study explored the relationship between use of antidepressants and level of alcohol consumption, examining whether using antidepressants affected the link between depression and level of alcohol consumption. The research conducted by the Centre for Addiction and Mental Health (CAMH) concluded that women suffering from depression consumed more alcohol than women who did not experience depression, regardless of antidepressant use. This finding differs significantly from rates found in male counterparts. While men suffering from depression generally consume more alcohol than non-depressed men, those who use antidepressants consume alcohol at about the same level as non-depressed men.

Dr. Kathryn Graham, Senior Scientist with CAMH and Agnes Massak, Ph.D student in the Department of Psychology at the University of Western Ontario, published the study in the Canadian Medical Association Journal (CMAJ) on February 27, 2007.

"Our results agree with previous clinical research that suggests that the use of antidepressants is associated with lower alcohol consumption among men suffering from depression," said Dr. Graham. "But this does not appear to be true for women."

Overall, participants in the survey experiencing depression (both men and women) drank more alcohol than did non-depressed respondents. However, men taking antidepressants consumed significantly less alcohol than depressed men who did not use antidepressants. Non-depressed men consumed 436 drinks per year, compared to 579 drinks for depressed men not using antidepressants, and 414 drinks for depressed men who used antidepressants.

Unfortunately for women, the alcohol use remained higher whether those experiencing depression took antidepressants or not. The numbers are telling: 179 drinks per year for non-depressed women, 235 drinks for depressed women not using antidepressants, and 264 drinks for depressed women who used antide
'"/>

Contact: David Coulombe
mediarelations@cihr-irsc.gc.ca
613-941-4563
Canadian Institutes of Health Research
26-Feb-2007


Page: 1 2

Related medicine news :

1. CIHR-funded research in Kenya
2. New nutritional research: College students face obesity, high blood pressure, metabolic syndrome
3. Healing from research: A real possibility
4. New pain research: Routine Tylenol for nursing home residents with dementia increases activity
5. Dementia research: Hope for the future
6. Antidepressants safe for children and adolescents
7. Antidepressants improve post-stroke thinking outside the box
8. Antidepressants associated with increased risk for suicide attempts, decreased risk for death
9. Antidepressants might reduce risk of colorectal cancer
10. Antidepressants may be associated with modestly increased risk of suicidality in children
11. Antidepressants and electroconvulsive therapy are the best treatment options for depression

Post Your Comments:
(Date:10/22/2014)... only 24 hours in a day, that doesn’t seem to be ... their busy schedules for exercise and fitness. Fortunately, one does not ... shape. Here are five ways you can reach your fitness and ... Commute , Consider riding a bike or taking the bus or ... If you must use your car to get to work, start ...
(Date:10/22/2014)... MA (PRWEB) October 22, 2014 ... new solutions for the treatment of bacterial infections, microbial ... Sinskey has joined its board of directors. , ... and Engineering Systems at The Massachusetts Institute of Technology, ... MIT faculty since 1968. Dr. Sinskey also holds positions ...
(Date:10/22/2014)... -- Two sisters in high school have developed ways ... Medha Krishen use electronic stethoscopes, which electronically amplify body ... patterns or heartbeats. Ilina, a senior at Port ... a way to detect early lung damage in people ... Ilina recorded one breath cycle each from 16 smokers, ...
(Date:10/22/2014)... 2014 (HealthDay News) -- Measures taken by Firestone officials ... Liberia may have limited the spread of the disease ... The Firestone Natural Rubber Co. provides health services to ... nearby densely populated communities. Between Aug. 1 and ... cases among those 80,000 people. That incidence rate of ...
(Date:10/20/2014)... The newly updated Worldwide Medical Market Forecasts ... facts, figures and forecasts on the global medical markets. ... categories the Worldwide Medical Market Forecasts to 2019 ... on the worldwide medical market to reveal key insights ... data for 2010-2019, covering each country market individually, allowing ...
Breaking Medicine News(10 mins):Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 4
(Date:10/22/2014)... -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ... focused on the development of oral drug delivery ... its Phase IIa clinical trial of ORMD-0801, the ... 1 diabetes. The trial was conducted in ... Food and Drug Administration (FDA) Investigational New Drug ...
(Date:10/22/2014)...   Surefire Medical , Inc., the developer of ... targeted delivery of embolization agents in minimally invasive direct-to-tumor ... John R. Daniels , MD of the University of ... Steven C. Katz , MD of the Roger ... Board (SAB).    "The role of the ...
(Date:10/22/2014)... NEW YORK , Oct. 22, 2014 ... and dermatology therapies. PV-10, its novel investigational drug for ... the potential for systemic side effects. Its oncology focus ... liver. Provectus has completed phase 2 trials of PV-10 ... as a topical treatment for atopic dermatitis and psoriasis. ...
Breaking Medicine Technology:Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 4Surefire Medical's Scientific Advisory Board Expands, Broadens Clinical Trial Expertise 2Provectus Biopharmaceuticals Looks at the Asian Markets: Analyst Coverage by Small Cap Traders 2
Cached News: